Related Experiment Videos
[Serotonin, food intake and body weight]
1Département de Psychologie, Université de Floride, Gainesville 32611.
Annales De Medecine Interne
|January 1, 1989
Summary
Dexfenfluramine effectively reduces food intake and promotes weight loss in various animal models of obesity and hyperphagia. This serotonin-releasing agent shows promise for managing overeating behaviors.
Area of Science:
- Neuropharmacology
- Obesity Research
- Animal Models
Context:
- Hyperphagia and obesity are complex conditions studied using diverse animal models.
- Dexfenfluramine, a serotonin (5-HT) modulator, is investigated for its effects on appetite regulation.
- Animal models include genetic (Zucker rat), hormonal (insulin, ovariectomy), VMH-lesioned, and dietary (cafeteria diet) induced obesity, as well as acute overfeeding paradigms.
Purpose:
- To evaluate the efficacy of dexfenfluramine in reducing food intake and body weight across various animal models of hyperphagia and obesity.
- To assess the impact of chronic dexfenfluramine administration on feeding behavior and weight management.
Summary:
- Dexfenfluramine was administered (3 mg/kg/day for up to 4 weeks) via osmotic minipump to multiple animal models exhibiting hyperphagia and obesity.
- These models encompassed chronic overfeeding conditions (hereditary, hormonal, dietary) and acute overfeeding stimuli.
- The study observed a consistent reduction in food intake and significant weight loss in most treated animals.
Impact:
- Dexfenfluramine demonstrates significant potential as an anti-obesity agent by modulating food intake.
- Findings support the role of serotonin pathways in regulating appetite and energy balance.
- This research provides a foundation for further investigation into dexfenfluramine's therapeutic applications in obesity management.